| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |